Regular use of aspirin for cardiovascular disease prevention in Italy

Preventive Medicine

Volumn 63, Issue , 2014, Pages 48-51

  Lugo, Alessandra ^a,b   Asciutto, Rosario ^c   Bosetti, Cristina ^a   Parazzini, Fabio ^b,d   La Vecchia, Carlo ^b   Gallus, Silvano ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Aspirin; Cardiovascular risk; Diabetes; Hypercholesterolemia; Hypertension; Italy; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOVASCULAR AGENT;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; DIABETES MELLITUS; EDUCATION; FEMALE; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; POPULATION; PREVALENCE; PRIORITY JOURNAL; SMOKING; YOUNG ADULT; AGED; CARDIOVASCULAR DISEASES; MIDDLE AGED; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84897008886     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2014.03.005     Document Type: Article

References (17)

1. Ajani U.A., Ford E.S., Greenland K.J., Giles W.H., Mokdad A.H. Aspirin use among U.S. adults: behavioral risk factor surveillance system. Am. J. Prev. Med. 2006, 30:74-77.
2. Araujo F., Gouvinhas C., Fontes F., La Vecchia C., Azevedo A., Lunet N. Trends in cardiovascular diseases and cancer mortality in 45 countries from five continents (1980-2010). Eur. J. Prev. Cardiol 2013, 10.1177/2047487313497864.
3. Arfe A., Malvezzi M., Bertuccio P., Decarli A., La Vecchia C., Negri E. Cancer mortality trend analysis in Italy, 1970-2007. Eur. J. Cancer Prev. 2011, 20:364-374.
4. Bosetti C., Tavani A., Negri E., Trichopoulos D., La Vecchia C. Reliability of data on medical conditions, menstrual and reproductive history provided by hospital controls. J. Clin. Epidemiol. 2001, 54:902-906.
5. Bosetti C., Rosato V., Gallus S., Cuzick J., La Vecchia C. Aspirin and cancer risk: a quantitative review to 2011. Ann. Oncol. 2012, 23:1403-1415.
6. Cleland J.G. Is aspirin useful in primary prevention?. Eur. Heart J. 2013, 34:3412-3418.
7. Cuzick J., Otto F., Baron J.A., et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol. 2009, 10:501-507.
8. Filippi A., Bianchi C., Parazzini F., Cricelli C., Sessa E., Mazzaglia G. A national survey on aspirin patterns of use and persistence in community outpatients in Italy. Eur. J. Cardiovasc. Prev. Rehabil. 2011, 18:695-703.
9. Fosbol E.L., Gislason G.H., Jacobsen S., et al. The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6million people. Pharmacoepidemiol. Drug Saf. 2008, 17:822-833.
10. Hennekens C.H., Dalen J.E. Aspirin in the treatment and prevention of cardiovascular disease: past and current perspectives and future directions. Am. J. Med. 2013, 126:373-378.
11. Motola D., Vaccheri A., Silvani M.C., et al. Pattern of NSAID use in the Italian general population: a questionnaire-based survey. Eur. J. Clin. Pharmacol. 2004, 60:731-738.
12. Perk J., De Backer G., Gohlke H., et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur. Heart J. 2012, 33:1635-1701.
13. Pignone M., Anderson G.K., Binns K., Tilson H.H., Weisman S.M. Aspirin use among adults aged 40 and older in the United States: results of a national survey. Am. J. Prev. Med. 2007, 32:403-407.
14. Pilotto A., Franceschi M., Leandro G., Di Mario F. NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies. Drugs Aging 2003, 20:701-710.
15. Rodondi N., Cornuz J., Marques-Vidal P., et al. Aspirin use for the primary prevention of coronary heart disease: a population-based study in Switzerland. Prev. Med. 2008, 46:137-144.
16. Temporelli P.L., Zito G., Faggiano P. Cardiovascular risk profile and lifestyle habits in a cohort of Italian cardiologists (from the Socrates Survey). Am. J. Cardiol. 2013, 112:226-230.
17. U.S.Preventive Services Task Force Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 2009, 150:396-404.